Mentice AB (MNTC) - Total Assets
Based on the latest financial reports, Mentice AB (MNTC) holds total assets worth Skr299.56 Million SEK (≈ $32.24 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check MNTC capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Mentice AB - Total Assets Trend (2017–2025)
This chart illustrates how Mentice AB's total assets have evolved over time, based on quarterly financial data. Check MNTC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Mentice AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Mentice AB's total assets of Skr299.56 Million consist of 56.4% current assets and 43.6% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 10.7% |
| Accounts Receivable | Skr111.06 Million | 35.6% |
| Inventory | Skr17.76 Million | 5.7% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr59.31 Million | 19.0% |
| Goodwill | Skr48.51 Million | 15.6% |
Asset Composition Trend (2017–2025)
This chart illustrates how Mentice AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Mentice AB market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mentice AB's current assets represent 56.4% of total assets in 2025, a decrease from 63.6% in 2017.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2025, down from 15.7% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 28.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 35.6% of total assets.
Mentice AB Competitors by Total Assets
Key competitors of Mentice AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
Mentice AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.99 | 0.86 | 1.03 |
| Quick Ratio | 0.89 | 0.75 | 0.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-1.97 Million | Skr-23.87 Million | Skr2.86 Million |
Mentice AB - Advanced Valuation Insights
This section examines the relationship between Mentice AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.42 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -3.7% |
| Total Assets | Skr312.02 Million |
| Market Capitalization | $38.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Mentice AB's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Mentice AB's assets decreased by 3.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Mentice AB (2017–2025)
The table below shows the annual total assets of Mentice AB from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr312.02 Million ≈ $33.58 Million |
-3.67% |
| 2024-12-31 | Skr323.90 Million ≈ $34.86 Million |
+0.43% |
| 2023-12-31 | Skr322.53 Million ≈ $34.71 Million |
-3.14% |
| 2022-12-31 | Skr332.98 Million ≈ $35.83 Million |
+27.14% |
| 2021-12-31 | Skr261.90 Million ≈ $28.19 Million |
+6.78% |
| 2020-12-31 | Skr245.27 Million ≈ $26.40 Million |
+31.06% |
| 2019-12-31 | Skr187.14 Million ≈ $20.14 Million |
+43.31% |
| 2018-12-31 | Skr130.59 Million ≈ $14.05 Million |
+39.19% |
| 2017-12-31 | Skr93.82 Million ≈ $10.10 Million |
-- |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more